Abstract
Congenital toxoplasmosis is asymptomatic in 85% of the cases and can flee detection due to a lack of a standard screening protocol. Management of foveal-threatening Toxoplasma retinochoroiditis is critical and involves pyrimethamine and sulfadiazine as the first-line treatment, but safer drugs like clindamycin and azithromycin are also available. We report two cases of bilateral congenital Toxoplasma retinochoroiditis in infants who were screened in the newborn intensive care unit (NICU), to highlight the importance of timely treatment with a combination of steroids and antibiotics in order to prevent vision-threatening sequelae.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
